Literature DB >> 23543375

Symptomatic bleeding from an intracerebral cavernoma after intravenous thrombolysis for ischemic stroke.

Thomas Gattringer, Alexander Pichler, Nina Homayoon, Kurt Niederkorn, Christian Enzinger, Franz Fazekas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23543375     DOI： 10.1007/s00415-013-6899-x

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  5 in total

Review 1.  The natural history of intracranial cavernous malformations.

Authors:  Bradley A Gross; Ning Lin; Rose Du; Arthur L Day
Journal:  Neurosurg Focus       Date:  2011-06       Impact factor: 4.047

2.  Intravenous thrombolysis in a patient with known cavernous malformation: a first case report.

Authors:  Nils Henninger; Nabil Ahmad; Jane G Morris
Journal:  Am J Emerg Med       Date:  2010-01       Impact factor: 2.469

3.  Bleeding of a familial cerebral cavernous malformation after prophylactic anticoagulation therapy. Case report.

Authors:  Eugenio Pozzati; Mino Zucchelli; Anna Federica Marliani; Luca Albini Riccioli
Journal:  Neurosurg Focus       Date:  2006-07-15       Impact factor: 4.047

Review 4.  Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation.

Authors:  Chad W Washington; Kathleen E McCoy; Gregory J Zipfel
Journal:  Neurosurg Focus       Date:  2010-09       Impact factor: 4.047

5.  Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations.

Authors:  Hans-Martin Schneble; Aicha Soumare; Dominique Hervé; Damien Bresson; Jean-Pierre Guichard; Florence Riant; Elisabeth Tournier-Lasserve; Christophe Tzourio; Hugues Chabriat; Christian Stapf
Journal:  Stroke       Date:  2012-11-13       Impact factor: 7.914
  5 in total
  2 in total

Review 1.  Stroke: an update.

Authors:  José M Ferro; Catarina Fonseca
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

2.  Off-label use of IV t-PA in patients with intracranial neoplasm and cavernoma.

Authors:  Christopher Jan Schwarzbach; Anne Ebert; Michael G Hennerici; Eva Neumaier-Probst; Michael Platten; Marc Fatar
Journal:  Ther Adv Neurol Disord       Date:  2018-02-05       Impact factor: 6.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.